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Prolonged seizures (status epilepticus, SE) may drive hippocampal dysfunction
and epileptogenesis, at least partly, through an elevation in neurogenesis,
dysregulation of migration and aberrant dendritic arborization of newly-formed
neurons. MicroRNA-22 was recently found to protect against the development
of epileptic foci, but the mechanisms remain incompletely understood. Here,
we investigated the contribution of microRNA-22 to SE-induced aberrant adult
neurogenesis. SE was induced by intraamygdala microinjection of kainic acid (KA) to
model unilateral hippocampal neuropathology in mice. MicroRNA-22 expression was
suppressed using specific oligonucleotide inhibitors (antagomir-22) and newly-formed
neurons were visualized using the thymidine analog iodo-deoxyuridine (IdU) and a
green fluorescent protein (GFP)-expressing retrovirus to visualize the dendritic tree
and synaptic spines. Using this approach, we quantified differences in the rate of
neurogenesis and migration, the structure of the apical dendritic tree and density and
morphology of dendritic spines in newly-formed neurons. SE resulted in an increased
rate of hippocampal neurogenesis, including within the undamaged contralateral
dentate gyrus (DG). Newly-formed neurons underwent aberrant migration, both within
the granule cell layer and into ectopic sites. Inhibition of microRNA-22 exacerbated
these changes. The dendritic diameter and the density and average volume of dendritic
spines were unaffected by SE, but these parameters were all elevated in mice in
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which microRNA-22 was suppressed. MicroRNA-22 inhibition also reduced the length
and complexity of the dendritic tree, independently of SE. These data indicate that
microRNA-22 is an important regulator of morphogenesis of newly-formed neurons in
adults and plays a role in supressing aberrant neurogenesis associated with SE.
Keywords: status epilepticus, epilepsy, neurogenesis, microRNA-22, mouse model
INTRODUCTION
Temporal lobe epilepsy (TLE) is the most common form
of drug-refractory acquired epilepsy in adults (Ramey et al.,
2013). TLE can emerge following an insult to the brain, such
as traumatic brain injury or period of status epilepticus (SE;
Pitkänen and Lukasiuk, 2009). A diverse set of molecular,
cellular and structural changes are consistently found in the
hippocampal formation of patients and animal models of
TLE, which are implicated in the formation of a network
with increased excitability and a lower threshold for seizure
generation (Pitkänen and Lukasiuk, 2009). Amongst these
epileptogenic processes are changes in receptor expression, the
formation of aberrant synaptic connections, gliosis, selective
cell loss and alterations to adult hippocampal neurogenesis
(AHN; Pitkänen and Lukasiuk, 2009; Jessberger and Parent,
2015).
Data from rodent models indicate that, following SE, AHN
increases sharply and remains elevated for up to 6 weeks (Parent
et al., 1997; Gray and Sundstrom, 1998; Jessberger et al., 2007;
Jessberger and Parent, 2015). Aberrant AHN not only involves
the dysregulation of cell division and proliferation, but also
of the maturation and morphology of newly-formed neurons
(Kelly and Beck, 2017), their electrophysiological properties
(Scharfman et al., 2000; Jakubs et al., 2006), migration (Han
et al., 2016) and functional integration into existing neuronal
circuits (Ge et al., 2007). This includes the aberrant migration of
a subpopulation of newly-formed dentate granule cells into the
dentate hilus, where they form a population of ectopic granule
cells (Parent et al., 1997).
MicroRNAs (miRNA) are small non-coding RNAs that
bind to target messenger RNA (mRNA) to reduce protein
production via Argonaute (AGO)-mediated translational
repression and other mechanisms (Bartel, 2004; Meister et al.,
2004). MiRNAs have important effects on brain excitability
and control several processes associated with epileptogenesis,
including inflammation, synaptogenesis and ion channel
expression (Jimenez-Mateos et al., 2015; Brennan and Henshall,
2018). Targeting key miRNAs using antisense oligonucleotide
inhibitors (antagomirs) can alter seizure susceptibility,
indicating the potential for miRNA-based therapeutics in
epilepsy (Jimenez-Mateos and Henshall, 2013; Reschke and
Henshall, 2015). A role for miRNAs has also been demonstrated
in regulating each stage of the process of AHN, including
proliferation, migration and dendritic arborization (Makeyev
et al., 2007; Han et al., 2016; Santos et al., 2016; Mahmoudi and
Cairns, 2017). Specific miRNAs also contribute to insult-induced
neurogenic dysfunction. For example, miR-155 is necessary for
inflammation-induced aberrant AHN (Woodbury et al., 2015).
To our knowledge, however, no miRNAs have been specifically
linked to the aberrant AHN that follows SE.
We recently screened AGO-bound miRNAs in the
hippocampus of mice subjected to intraamygdala kainic
acid (KA)-induced SE, identifying miR-22–3p (miR-22) as the
most highly upregulated in the cell death spared, contralateral
hippocampus (Jimenez-Mateos et al., 2015). Blocking miR-
22, using antagomirs, resulted in exacerbation of subsequent
spontaneous recurrent seizures (SRS) in mice, mediated in part
by de-repression of the purinergic P2X7 receptor (Jimenez-
Mateos et al., 2015; Engel et al., 2017). MiR-22, however, is
likely to regulate other processes, besides inflammation (Xiong,
2012; Wang et al., 2017). Notably, miR-22 is also expressed
in the neurogenic subgranular zone (Jimenez-Mateos et al.,
2015) and has been implicated in controlling neurogenesis
during development including lengthening of the cell cycle
(Berenguer et al., 2013) and regulating cell migration (Volvert
et al., 2014).
Here, we explored whether miR-22 regulates SE-induced
aberrant AHN, focusing on the contribution of miR-22 to the
regulation of the rate of adult neurogenesis, aberrant migration,
dendritic arborization and the density and morphology of
dendritic spines of newly-formed granule cells, both under
normal conditions and following a period of KA-induced SE. Our
results demonstrate that SE with a focal onset triggers aberrant
adult neurogenesis, even in the contralateral dentate gyrus (DG)
and that inhibition of miR-22 exacerbates multiple parameters
including dendritic diameter and the density, volume and
morphological maturity of dendritic spines. Further, dendritic
length and complexity is unaffected by SE, but is modulated,
independently of this insult, by miR-22.
MATERIALS AND METHODS
Animal Model of Epilepsy
All animal procedures were performed in accordance with the
principles of the European Communities Council Directive
2010/63/EU and National Institute of Health’s Guide for the
Care and Use of Laboratory Animals. All studies involving
animals were approved by the Research Ethics Committee of
the Royal College of Surgeons in Ireland (REC 205 and 1322)
and the Centro de Biología Molecular Severo Ochoa Institutional
Animal Care and Utilization Committee (Comité de Ética de
Experimentación Animal del CBM, CEEA-CBM), Madrid, Spain
(PROEX293/15).
SE was induced in 10 week-old (20–25 g) adult male mice
C57Bl/6 and P2rx7-green fluorescent protein (GFP) expressing
mice [Tg(P2rx7-EGFP)FY174Gsat/Mmcd, stock 011959-UCD],
from U.S. National Institutes of Health Mutant Mouse Regional
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Resource Centers and granted by Dr. M. Nedergaard (University
of Rochester, Rochester, NY, USA) by unilateral stereotaxic
microinjection of KA into the amygdala, as previously described
(Moran et al., 2013). Briefly, deeply anesthetized mice (isoflurane
3%–5% induction and 1%–2% maintenance) were fitted with
a guide cannula affixed over the dura using dental cement
(coordinates from Bregma: AP= −0.94; ML= −2.85 mm) for the
injection of KA. KA was injected via a 31-gauge internal cannula
into the amygdala (0.3 µg in 0.2 µl vehicle; phosphate-buffered
saline (PBS), pH adjusted to 7.4). Non-seizure control mice
received 0.2 µl vehicle. Lorazepam (6 mg/kg, intraperitoneal)
was administered 40 min following KA injection. Mice were
euthanized at different time points following SE and brains
perfused with PBS and 4% paraformaldehyde (PFA) for analysis.
Antagomir Injection
MiR-22 inhibiting antagomirs (locked nucleic acid (LNA)-
and 3′-cholesterol modified oligonucleotides; antagomir-22,
Ant22) were administered via intra-cerebro-ventricular (i.c.v.)
injection, as previously described (Jimenez-Mateos et al.,
2015; Engel et al., 2017). Ant22 and a scrambled control
(Scr) were purchased from Exiqon (Vadbaek, Denmark). The
Ant22 sequence was CTTCAACTGGCAGCT and Scr sequence
was ACGTCTATACGCCCA. Mice received 2 µl infusion of
0.5 nmol Ant22/Scr dissolved in PBS into the contralateral third
ventricle 24 h prior to the induction of SE.
Diaminobenzidine Staining and
Immunohistochemistry
Diaminobenzidine (DAB) staining was carried out as previously
reported (Engel et al., 2013). Mice were perfused with 4% PFA,
brains post-fixed and cryoprotected in 30% sucrose solution,
and 30 µm sagittal sections were cut on a Leica cryostat. Brain
sections were then pre-treated for 1 h with 1% bovine serum
albumin (BSA), 5% fetal bovine serum and 0.2% TritonTM X-100
followed by an overnight incubation with the primary antibody
against the P2X7 receptor (1:400, Alomone, Jerusalem, Israel).
Brain sections were then incubated in avidin–biotin complex
using the Eliter VECTASTAINr kit (Vector Laboratories
Peterborough, UK). Chromogen reactions were performed with
DAB and 0.003% hydrogen peroxide for approximately 10 min.
Sections were coverslipped with FluorSaveTM.
Immunohistochemistry was performed as previously
described (Engel et al., 2017). Briefly, 50 µm thick sagittal
brain sections were cut on a Leica VT1200S vibratome, with
series of every 8th section produced and stored at −20◦C
in glycoprotectant. Unless otherwise stated, procedures were
carried out at room temperature. Sections were incubated in
0.1% Triton (in PBS) for 15 min, followed by 30 min in 1 M
glycine, rinsed several times in PBS and incubated in 1% BSA
for 45 min. Sections were again rinsed in PBS before being
incubated overnight in primary antibody at 4◦C. The next day,
following washing in PBS, sections were incubated in secondary
antibody for 2 h. Sections were then rinsed several times in PBS
and incubated for 15 min in 4′,6-Diamidino-2-Phenylindole
(DAPI, Calbiochem, San Diego, CA, USA) at a concentration of
1:500. Sections were again rinsed several times in PBS, rinsed in
distilled water mounted and coverslipped with FluorSaveTM. The
following primary antibodies were used: Goat anti-Doublecortin
(anti-DCX; Santa Cruz Biotechnology, Dallas, TX, USA, 1:400),
Mouse anti-NeuN (Merck Millipore, Tullagreen, Ireland, 1:400),
Rabbit anti-GFAP (Cell Signaling, Danvers, MA, USA, 1:400)
and Rabbit anti-GFP Molecular Probes (Invitrogen, Waltham,
MA, USA, 1:400). Immunostaining with 5-iodo-2-deoxy-uridine
(IdU) included a 30 min pretreatment with HCl 2N, followed
by 30 min in borate buffer. The following secondary Alexa-
conjugated antibodies were used at a final concentration of
1:400: Alexa 555-conjugated anti-goat; Alexa 555-conjugated
anti-rabbit; Alexa 555-conjugated anti-mouse and Alexa
488-conjugated anti-rabbit (Life Technologies, Waltham, MA,
USA).
Western Blotting
Western blotting was performed as previously described
(Engel et al., 2010). Thirty microgram of protein samples
were boiled in gel-loading buffer and separated by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Proteins were transferred to nitrocellulose membranes and
probed with the following primary antibodies: α-Tubulin
(1:1,000, Sigma-Aldrich, Wicklow, Ireland) and P2X7
(1:400, Alomone, Jerusalem, Israel). Next, membranes were
incubated with horseradish peroxidase-conjugated secondary
antibodies (1:2,000, Isis Ltd, Bray, Ireland) and protein bands
visualized using chemiluminescence (Pierce Biotechnology,
Rockford, IL, USA). Gel bands were captured using a Fujifilm
LAS-3000 (Fujifilm, Tokyo, Japan) and analyzed using Alpha-
EaseFC4.0 software.
Electrophysiological Recordings in Brain
Slices
Electrophysiological recordings were carried out as previously
described (Jimenez-Mateos et al., 2015). Briefly, 300 µm
sagittal sections were cut using a vibratome (Integraslice
7550, Campden Instruments) from whole-brains from epileptic
P2rx7-GFP expressing mice (14 days post-SE) and incubated
in saline solution continuously bubbled with carbogen (95%
O2/5% CO2) at room temperature for a maximum of 6 h
before being transferred to the recording chamber. Slices were
transferred to a submersion chamber attached to the stage
of an upright microscope (Olympus BX51W1; UK), fixed
with a nylon grid and superfused with a saline solution.
Cells were viewed under a 63× water immersion objective,
with fluorescence illumination and a DL-604 OEM camera
(Andor Technology, EU) used to visualize GFP-cells in the
DG region of the hippocampus. Electrophysiological recordings
were performed with an EPC10/2 patch-clamp amplifier using
PatchMaster software (HEKA Electronic, Lambrecht, Germany).
Patch pipettes had a final resistance of 5–6 M when filled
with a solution containing (in mM) 140 N-Methyl-D-glucamine
(NMDG+), 5 EGTA, 3 MgCl2 and 10 HEPES (pH 7.2, adjusted
with HCl; ≈290 mOsm). Membrane currents, measured in
whole-cell configuration, were filtered at 3 kHz and sampled at
10 kHz. Once electrical access to the cytoplasm was established,
cells were held at a voltage (V) of −70 mV. Series resistance
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(5–10 M) was compensated by 80% and monitored throughout
the experiment together with the cell membrane capacitance.
Drug application was started at least 10 min after obtaining
the whole-cell configuration, and experiments in which series
resistance changed by more than 20% or holding current
exceeded 20 pA were discarded. All recordings were obtained
at room temperature. Currents were induced by 2′3′-O-
(4-Benzoyl)benzoyladenosine 5′-triphosphat (BzATP; 100 µM;
Sigma-Aldrich, Wicklow, Ireland) applied for 3 s at 2 min
intervals onto the cell under investigation by means of a
pneumatic drug ejection system (PDES-02DX, NPI Electronic
GmbH, Germany). A-438079 (10 µM; Sigma-Aldrich, Wicklow,
Ireland), a specific P2X7 antagonist, was applied from a separate
glass pipette 2 min prior to, and during, agonist administration.
MiRNA Extraction and Analysis
Total RNA was extracted using the Trizol method (Engel et al.,
2013). The quality and quantity of RNA were measured using
a Nanodrop Spectrophotometer (Thermo Scientific CA, USA)
and samples with an absorbance ratio at 260/280 between
1.8 and 2.2 were considered acceptable. RNA dilutions were
made up in nuclease-free water. For miRNA analysis, reverse
transcription for individual qPCR was carried out using 500 ng
of total RNA and the High-Capacity Reverse Transcription
Kit (Applied Biosystems CA, USA). RT specific primers for
miR-22 (ID: 000398. Thermo Fisher, CA, USA) were used for
all miRNA reverse transcription. Individual qPCRs were carried
out on the QuantStudio 12k Flex System (Thermo Fisher, CA,
USA) using miR-22 specific Taqman microRNA assays (Thermo
Fisher CA, USA). RNU6B (ID: 001093, Thermo Fisher CA,
USA) was used for normalization of miRNA expression. A
relative fold change in expression of the target gene transcript
was determined using the comparative cycle threshold method
(2−∆∆CT).
Temporal Lobe Epilepsy Patient Brain
This study was approved by the Ethics (Medical Research)
Committee of Beaumont Hospital, Dublin (05/18), and written
informed consent was obtained from the patient. The TLE
patient used in our study has been referred for surgical resection
of the temporal lobe for the treatment of intractable TLE. After
temporal lobe resection, hippocampal tissue was obtained and
frozen in liquid nitrogen and stored at −80◦C until use. A
pathologist assessed the hippocampal tissue and confirmed the
presence of hippocampal sclerosis.
In situ Hybridization
In situ hybridization was carried out as previously described
(Jimenez-Mateos et al., 2012). Using RNAse free solutions,
slides were treated with 0.25% acetic anhydride/0.1 M
triethanolamine, followed by 5 µg/ml of proteinase K.
Next, slides were rinsed in hybridization buffer. The probes
to detect miR-22 or the positive control snRNA U6 were
2′-O, 4′-C methylene bicyclonucleoside monomer-containing
oligonucleotides (LNA-modified; Qiagen, Vedbaek, Denmark).
The nucleotide sequence for the anti-miR-22 probe was
CTTCAACTGGCAGCTT/3Dig_N. A scrambled probe was
also included to assess non-specific binding (Qiagen, Vedbaek,
Denmark). Probes were incubated in 1:200 hybridization
buffer overnight at 60◦C. Sections were washed and then
incubated with anti-DIG-PA antibody (1:1,000, Roche, Dublin.
Ireland). The following day, sections were washed again and
then reacted with color substrate solution (CSS: Nitroblue
tetrazolium/BCIP stock solution; Roche, Dublin, Ireland).
Slides were then rinsed, mounted and coverslipped with
FluorSaveTM.
Iodo-deoxyuridine Administration
Mice were injected with a single injection of IdU (42.75 mg/kg
intraperitoneal; Sigma-Aldrich Arklow, Ireland) 72 h following
SE. IdU dose used was based on an equimolar dose of 50 mg/kg
5-bromo-2′-deoxyuridine (BrdU).
Cell Counting
To determine the number of P2X7-positive cells in the
subgranular zone of the DG in Ant22 and Scr-treated epileptic
mice, sagittal-cut brain slices were DAB-stained at the level of
Bregma: AP = −1.94 mm. P2X7-positive cells were counted
only within the dentate granular cell layer. Each count was
the average of two adjacent slices. IdU was visualized via
immunohistochemistry 6 weeks following SE as described above.
Each count was the average of two adjacent slices (Bregma
AP = −1.94 mm) including the dentate granular cell layer and
the area of the hilus. The same counting procedure was used to
calculate numbers for DCX-positive cells.
Calculating Migration of Newly-formed
Neurons
A common consequence of SE is dispersion of dentate granule
cells (Murphy et al., 2012), leading to an increased width of
the granular cell layer. This phenomenon has the potential to
confound results for migration of newly-formed neurons, if
using distance from the subgranular zone as the measurement.
In order to control for this, we measured, not only distance
from the subgranual zone (dSGZ), but also from the outer edge
of the blade (dOE) and calculated migration as the percentage
of granular cell layer width traversed by each cell, using the
following calculation: dSGZ/(dSGZ+dOE)∗100.
Retroviral Stock Preparation
For labeling newly-formed neurons, a retroviral vector encoding
postsynaptic density protein 95 (PSD95) fused to GFP (PSD95-
GFP) was used. The vectors were provided by Prof. Lois
(Department of Brain and Cognitive Science, Massachusetts
Institute of Technology) and the methods for the generation
of the vector have been described in detail elsewhere (Kelsch
et al., 2008; Llorens-Martín et al., 2016). The PSD95-GFP
retrovirus allows for visualization of dendritic spines under
the green channel. Moreover, anti-GFP immunohistochemistry
(red channel) allowed visualization of the whole neuronal
morphology (Kelsch et al., 2008). Retroviral stocks were
concentrated to working titers of 1 × 107–2 × 108 pfu/ml by
ultracentrifugation. Since the retroviruses used are engineered
to be replication incompetent, only dividing cells at the time
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of surgery can be infected (Kelsch et al., 2008). Four to six
mice per experimental group were injected with the virus into
the contralateral DG (coordinates from Bregma: AP:−2.0 mm,
ML = 2.2 mm, DV 2.2 mm) using glass micropipettes, 1
week following SE. A total volume of 2 µl per contralateral
DG of the viral suspension at a concentration of 107–108
pfu/ml was infused at 0.2 µl/min using an automatic infusion
pump. Mice were killed 6 weeks following virus injection by
intraperitoneal injection with pentobarbital and transcardially
perfused with 0.9% saline solution followed by 4% PFA in PBS.
Brains were removed and post-fixed overnight at 4◦C in the same
fixative.
Morphometric Analysis
Three series of sections from each animal were used for the
immunohistochemical detection of GFP. At least 50 randomly
selected neurons from each experimental condition were
reconstructed under a LSM710 Zeiss confocal microscope
(25× oil immersion objective). Confocal stacks of images
were obtained (Z-axis interval: 2 µm) and Z-projections were
analyzed for the determination of total dendritic length and
Sholl analysis. All cells were traced using the NeuronJ plugin
for ImageJ software (ImageJ v.1.47, NIH, USA1). Sholl analysis
was performed using the plugin Sholl Analysis for ImageJ. This
analysis consists of placing a central point on the cell soma
and tracing concentric circles (separated by a 50 µm distance
interval). The number of times that the dendritic tree intersects
with each circle is represented in the graphs (number of
crossings). The Schoenen ramification index (SRI), which is
the highest number of dendritic crossings at any single radius
from the cell soma, was calculated as previously (Schoenen,
1982).
Analysis of Dendritic Diameter
Dendritic trees were visualized in three dimensions using
NeuronStudio (CNIC, Mount Sinai School of Medicine). Trees
were traced using the in-built algorithm, detecting the intensity
of fluorescence in three dimensions and corrected manually.
Average diameter for each branch and for the entire tree of
GFP-positive neurons were calculated.
Calculation of Numbers of
PSD95-GFP-Positive Clusters
PSD95-GFP-positive clusters were examined in each dendritic
tree branching order. A minimum of 30 segments belonging
to each experimental condition were analyzed for each
branching order. Confocal stacks of images were obtained
in a LSM710 Zeiss confocal microscope (63× oil immersion
objective, XY dimensions: 67.4 µm; Z-axis interval: 0.13 µm).
Dendritic trees were visualized in three dimensions using
NeuronStudio. The dendritic length of each segment was
measured (red channel, GFP), and the number, size (volume) and
morphology was analyzed. Morphology of spines was assessed
by the ratio of the head/neck. Spines with a head diameter
greater than 0.4 µm and a head/neck ratio greater than 1.2
1http://rsbweb.nih.gov/ij/
(Bourne and Harris, 2011) were considered ‘‘mushroom-shaped’’
spines.
Data Analysis
All data are presented as mean ± standard error of the mean.
Statistical analysis was performed using Graphpad Prism 5.
Two group comparisons were made using unpaired Student’s
t-test, while multi-group comparisons were made using two-way
analysis of variance (ANOVA), with Tukey’s honest significant
difference test (Tukey’s HSD) used for post hoc pairwise
comparisons. Repeated measures two-way ANOVA was used
to make comparisons between groups where a series of
measurements have been taken from the same cell at different
dendritic orders. In this case, post hoc pairwise comparisons
were carried out using Bonferroni post hoc tests. Where groups
contained a mean of zero (e.g., Figures 3E,G), these columns
were removed from statistical analysis and Student’s t-test
was used to make comparisons between non-zero columns. In
Figure 1I, no statistical analysis was performed as one treatment
group had a mean of zero.
RESULTS
Increased miR-22 Expression and Function
in the Contralateral Hippocampus After
Status Epilepticus
To elucidate the role of miR-22 in regulating AHN following
SE, mice were given a unilateral microinjection of KA into
the amygdala (Mouri et al., 2008; Figure 1A). In this model,
prolonged seizures spread bi-laterally through the limbic
system causing neurodegeneration in the ipsilateral but not
contralateral hippocampus. The lesion is principally confined
to the ipsilateral CA3 subfield. Epilepsy develops in all mice
following a short latent period of 2–5 days with mice typically
experiencing between 1–5 SRS per day (Mouri et al., 2008).
We recently found miR-22 to be the most highly up-regulated
miRNA in the contralateral hippocampus in the model and
showed inhibition of this miRNA results in the generation
of a secondary epileptogenic focus (Jimenez-Mateos et al.,
2015).
First, we investigated miR-22 expression in the contralateral
hippocampus during epilepsy development in the model. Levels
of miR-22 were increased following SE in the DG (Jimenez-
Mateos et al., 2015) and this elevation persisted into the
time when SRS were actively occurring (Figure 1B). To
identify the location of this upregulation we stained tissues
sections for miR-22. In situ hybridization revealed that miR-22
was particularly evident in the subgranular zone of the DG
corresponding to sites of enhanced neurogenesis after SE
(Figure 1C). To determine whether miR-22 is also expressed in
DG in epilepsy patients, we stained for miR-22 in hippocampal
tissue resected from a drug-resistant TLE patient. This revealed
miR-22 is highly expressed in the DG in human TLE (Figure 1D).
To investigate the functional contribution of miR-22 to
AHN, we used a specific inhibitor of miR-22, antagomir-22
(Ant22). We have previously demonstrated that a single i.c.v.
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FIGURE 1 | Increased miR-22 levels in the contralateral hippocampus during epilepsy in mice. (A) Schematic showing intraamygdala injection of kainic acid (KA) into
the ipsilateral amygdala to induce status epilepticus (SE). (B) Graph showing increased levels of miR-22 in the contralateral dentate gyrus (DG) 2 weeks following SE
(n = 4 per group, Student’s t-test: ∗t = 3.483, p = 0.0131). (C) In situ hybridization showing miR-22 in the DG of the contralateral hippocampus in non-epileptic
control vehicle-injected mice and in mice subjected to SE. Of note, miR-22 levels seem to be mainly increased in the subgranular zone in the DG of the contralateral
hippocampus during epilepsy (6 weeks following SE). Scale bar = 50 µm. (D) MiR-22 expression in the hippocampus in a patient suffering from temporal lobe
epilepsy (TLE). MiR-22-positive cells were mainly localized to the DG (arrows and magnification). snRNA U6 was used as positive control. Scale bar = 1 mm.
(E) Graph showing decreased miR-22 levels in the hippocampus (n = 4 per group Student’s t-test: ∗∗t = 4.955, p = 0.0026). (F) In situ hybridization showing
decreased miR-22 levels in the subgranular zone of the DG 6 weeks following intra-cerebro-ventricular (i.c.v.) injection of Ant22. Scale bar = 50 µm. (G) Decreased
P2X7 receptor expression in the contralateral hippocampus of epileptic mice 14 days following SE when compared to control mice (n = 4 per group, Students t-test:
∗t = 2.734, p = 0.034). (H) Lower BzATP-provoked currents detected by patch clamp from green fluorescent protein (GFP)-positive cells present in the contralateral
DG of the hippocampus of epileptic P2rx7-GFP expressing mice when compared to GFP-positive cells from the ipsilateral DG 14 days following SE (n = 19 cells for
ipsi- and 17 cells from contralateral hippocampus from nine mice per group, Student’s t-test, ∗t = 2.673, p = 0.0115). Scale bar = 50 µm. (I) Increased
P2X7 receptor expression mainly localized to the subgranular zone of the DG of the contralateral hippocampus (arrows) in mice treated with Ant22 6 weeks following
SE when compared to scramble-treated epileptic mice. n = 5, Scale bar = 50 µm.
injection of 0.5 nmol of Ant22 reduces miR-22 levels in
the hippocampus by over 70% for up to 2 weeks (Jimenez-
Mateos et al., 2015). We now demonstrate by performing
qPCR with hippocampal tissue from Scr-injected and Ant22-
treated mice that this effect persists beyond this time point,
with miR-22 expression suppressed for the full duration
of this study (6 weeks; Figure 1E). In situ hybridization
confirmed Ant22 reduced miR-22 expression in the DG and
this lasted as long as 6 weeks following Ant22 administration
(Figure 1F).
To extend the AGO-miRNA profiling evidence that miR-22
is functional in the contralateral hippocampus from epileptic
mice, we measured changes to the purinergic P2X7 receptor,
a validated miR-22 target (Jimenez-Mateos et al., 2015; Engel
et al., 2017). Hippocampal protein expression of P2X7 was
lower in the contralateral hippocampus of epileptic mice
when compared to control mice (Figure 1G). To determine
whether this decrease occurs in the subgranular zone, we
visualized cells expressing the target P2rx7 transcript using
a transgenic mouse that expressed GFP driven by the
P2X7 promoter (P2rx7-GFP; Engel et al., 2012). Whereas the
GFP signal was evident in both the ipsi- and contralateral
hippocampi of epileptic mice 2 weeks following SE, particularly
in NeuN-positive neurons of the DG (Figure 1H), patch-
clamp recordings demonstrated a stronger current induced
by the P2X7 agonist BzATP in GFP-positive cells in the
ipsilateral DG, when compared to the contralateral DG
(Figure 1H). This suggests post-transcriptional repression
of P2X7 in the contralateral hippocampus. In line with
miR-22 targeting P2X7 during epilepsy (Engel et al., 2017),
P2X7 protein levels in the contralateral hippocampus are
higher in Ant22-treated epileptic mice when compared to
epileptic Scr-treated mice, even 6 weeks following SE with
this increase most evident in the subgranular zone of the DG
(Figure 1I).
Taken together, our data reveal SE induces lasting
upregulation and functional engagement of miR-22 in the
contralateral hippocampus which is associated with a particular
enrichment of miR-22 in the subgranular zone.
Status Epilepticus-Induced Elevation in
Neurogenesis Is Exacerbated by miR-22
Suppression
We have previously demonstrated that pre-treatment
with Ant22 has no impact on the severity of SE
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FIGURE 2 | Increased neurogenesis 6 weeks following SE in mice with suppressed miR-22 expression. (A) Graph and representative images showing more
Doublecortin-(DCX)-positive cells in the hippocampus of epileptic mice. DCX-positive cell numbers were even higher in epileptic mice treated with Ant22 when
compared to epileptic mice treated with Scr (n = 3 (Scr Cont), 4 Ant22 (Cont and KA) and 6 (Scr KA), one-way ANOVA: F(3,15) = 41.01, p < 0.0001; post hoc test
(Bonferroni): ∗∗∗t = 4.979, p < 0.001 (scramble/veh vs. scramble/KA); ∗∗∗t = 9.726 (scramble/veh vs. antagomir/KA); ###t = 5.437, p < 0.001). Scale bar = 50 µm.
(B) Graph and representative images showing more IdU-positive cells in epileptic mice 6 weeks following SE compared to control mice. The number of IdU-positive
cells was also increased in epileptic mice treated with Ant22 when compared to Scr-treated epileptic mice (n = 3 (Scr Cont), 4 Ant22 (Cont and KA) and 6 (Scr KA),
One-way ANOVA: F(3,12) = 2.951 p < 0.0001 post hoc tests (multiple-comparisons Bonferroni): ∗∗t = 5.308, p < 0.01; ∗∗∗t = 8.285, p < 0.001; #t = 2.978,
p < 0.05). Blue: nuclear marker DAPI, Red: IdU-positive cells. Scale bar = 50 µm. (C) Graph and representative image showing percentage of NeuN-positive IdU
cells in the DG of the contralateral hippocampus 6 weeks following intraamygdala KA injection. Red: NeuN, Green: IdU (n = 3 (Scr Cont), 4 Ant22 (Cont and KA) and
6 (Scr KA). Scale bar = 20 µm.
(Jimenez-Mateos et al., 2015), however mice treated with
Ant22 go on to develop a more severe epilepsy phenotype
including the generation of a secondary, contralateral epileptic
focus. The localization of miR-22 in the subgranular zone
of the contralateral hippocampus following SE suggests that
miR-22 may play a role in mediating SE-induced AHN. To
investigate this, we studied the effects of miR-22 inhibition
on neurogenesis following SE. Counts of DCX, a protein
expressed in newly-formed migrating neuroblasts (von Bohlen
und Halbach, 2007) revealed that 6 weeks following SE,
DCX-positive cells were increased approximately 3-fold,
compared to vehicle-injected non-seizure mice in the DG of
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the contralateral hippocampus (Figure 2A). DCX cell counts
were approximately doubled in epileptic mice treated with
Ant22 when compared to epileptic Scr-treated mice (Figure 2A).
Inhibition of miR-22 in normal mice did not alter DCX counts
(Figure 2A). These findings suggest that miR-22 may normally
function to restrict the excess production of DCX-positive cells
following SE.
To extend these findings, an additional set of mice were
injected with a marker of dividing cells, IdU, 72 h following SE.
Brains were then analyzed 6 weeks later. Supporting the DCX
findings, the number of IdU-positive cells in the contralateral DG
was elevated by approximately 75% in Scr-treated animals subject
to SE 6 weeks earlier. IdU-labeling was approximately doubled
in mice in which miR-22 was inhibited by Ant22 (Figure 2B).
Ant22 did not affect IdU incorporation in non-seizure mice
(Figure 2B).
To identify the phenotypes of these new-born cells, we
counterstained IdU-labeled sections with the neuronal marker
NeuN. This analysis revealed that the majority of IdU-positive
cells were mature neurons (∼80%). This distribution was similar
between Scr and Ant22-treated mice indicating that miR-22
inhibition does not alter cell ontology (Figure 2C).
These findings indicate that miR-22 may act as a brake on
excessive neurogenesis within the contralateral hippocampus in
this model of focal-onset SE.
MiR-22 Attenuates Neurogenesis and
Aberrant Neuronal Migration in Mice
Following Status Epilepticus
Our IdU findings suggest that most of the surviving newly-
formed cells following SE become neurons. In order to
investigate whether miR-22 influences the development of
these neurons, we injected the contralateral DG of mice,
1 week following SE, with a retrovirus expressing GFP-tagged
to the post-synaptic marker PSD-95 (Kelsch et al., 2008).
GFP-expressing cells were identified in tissue sections using
anti-GFP immunostaining 6 weeks later (Figure 3A). Analysis of
GFP-positive cells revealed inhibition of miR-22 after SE induced
an increase in AHN in mice (Figures 3B,C). Ant22 did not alter
the number of GFP-positive cells in non-seizure control mice
when compared to control Scr-injected mice (Figures 3B,C).
Although viral infection is not considered a quantitative measure
of neurogenesis, these findings are in line with our findings from
DCX staining and IdU-labeling.
In order to measure whether miR-22 impacts on the
migration of newly-formed neurons following SE, we measured
migration of GFP-positive cells as a percentage of the width of the
granule cell layer crossed from the subgranular zone (Figure 3D).
In control mice, new neurons were only found within 5% of the
inner edge of the granule cell layer. Ant22 treatment had no effect
on migration in control mice, compared with Scr-treated mice
(Figure 3D). Following SE, however, GFP-labeled neurons in
Scr-treated mice had migrated across an average of 12% of the
width of the granule cell layer. This SE-induced dysregulation
of migration was exacerbated by Ant22 treatment, where the
average migration of newly-formed neurons was 22% of the
width of the granule cell layer (Figure 3D). This finding suggests
that miR-22 functions to restrict aberrant migration of new-born
neurons after SE.
SE also induced aberrant migration into the dentate hilus
(Figure 3E). No ectopic hilar granule cells were found
in non-seizure mice, whether treated with Scr or Ant22
(Figure 3E). Following SE, however, a small population of
ectopic granule cells were found in the hilus in Scr-treated
mice (approximately 2% of the total population of GFP-positive
newly-formed neurons; Figure 3E). This was exacerbated in
mice treated with Ant22, when compared with Scr-treated
mice, with approximately 4.5% of GFP-positive, newly-formed
neurons found in ectopic locations within the DG (Figure 3E).
Confirming these results and excluding that the expression
of GFP-retrovirus itself had an effect on migration of
newly-formed neurons, the same results were obtained when
analyzing IdU-positive cells with mice subjected to SE showing
a dysregulated migration of newly-formed neurons which
was exacerbated in Ant22-treated mice (Figure 3F). Ectopic
IdU-positive neurons located in the hilar region were only
found in epileptic mice, whether pre-treated with Scr or
Ant22. Again, this was more pronounced in Ant22-treated mice
(Figure 3G). All GFP-positive cells, whether in the granular cell
layer or ectopically expressed, were DCX-negative (Figure 3H),
confirming that this population of cells were identifiably mature
neurons.
Together, these results suggest that miR-22 may function to
oppose aberrant migration of new neurons in the hippocampus
after SE.
MicroRNA-22 Inhibition Reduces the
Complexity of the Dendritic Tree
We next analyzed the dendritic tree of PSD95-GFP-positive
neurons in tissue sections from mice given Scr or Ant22. SE
had no effect on dendritic length. Mir-22 inhibition, however,
had a highly significant effect on dendritic length, although
pair wise comparisons did not demonstrate a difference in either
KA or vehicle-treated groups (Figures 4A,B). In line with
these observations, a Sholl analysis (Figure 4C) indicated that
inhibition of miR-22 leads to a shift of the branching distribution
in newly-formed neurons (Figures 4D,E). Newly-formed granule
neurons originating in a miR-22-deprived environment showed
a decrease in the number of branches in the proximal segment of
the neuron, represented by a decrease in the number of crossings
close to the soma (Figures 4D,E). Induction of SE decreased the
overall complexity of the dendritic tree (Figures 4D,E). Whilst
there was a trend towards a decreased complexity associated with
Ant22-treatment, this was not significant.
To further characterize the morphology of the dendritic
tree, we measured the dendritic diameter in newly-formed
neurons. Neither SE nor Ant22 alone had an effect on the
diameter of dendrites in GFP-positive, newly-formed neurons.
In Ant22-treated mice, however, SE induced a significant
increase in dendritic diameter (Figure 4F). This was particularly
pronounced at higher dendritic orders (Figure 4G).
Our results suggest a key role for miR-22 in controlling
dendritic tree formation, with suppression of miR-22 resulting
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FIGURE 3 | Viral transfection of postsynaptic density protein 95 (PSD95)-GFP of scramble and antagomir-22 treated mice following SE. (A) Schematic time-course
of experimental design. Twenty four hours following i.c.v. injection of Ant22/Scr, mice were injected with intraamygdala KA to induce SE which was terminated with
lorazepam (Lz). One week following SE, mice were injected into the contralateral DG with PSD95-GFP expressing retrovirus and brain analyzed 6 weeks later.
(B) Representative images of the contralateral DG from Scr and Ant22-treated control and epileptic mice 6 weeks following transfection with PSD95-GFP. Virus was
injected 1 week post-SE. Note, strong increase in GFP-positive cells in the contralateral DG in Ant22-treated epileptic mice. Scale bar = 200 µm. (C) Graph showing
more PSD-95-GFP-positive cells in the contralateral DG in Ant22 treated mice (two-Way ANOVA: Scr vs. Ant22 (∗∗∗F(1,16) = 25.93, p < 0.001); Veh vs. KA
(∗∗∗F(1,16) = 91.810, p < 0.001), interaction (∗∗∗F(1,16) = 20.28, p < 0.001). Post hoc tests (Tukey’s HSD): Veh/Scr vs. Veh/Ant22: n.s, p = 0.975; ∗Veh/Scr vs.
KA/Scr: p = 0.012; ∗∗∗KA/Scr vs. KA/Ant22: p < 0.001. (D) Representative image of migration calculation and graph showing mean (± SEM) distance traveled by
PSD95-GFP-positive newly-formed neurons as percentage of width of granule cell layer (two-way ANOVA: Ant22 vs. Scr (∗∗F(1,16) = 15.94, p = 0.001); Veh vs. KA
(∗∗∗F(1,16) = 94.88, p < 0.0001), interaction (∗∗F(1,16) = 9.65, p = 0.007). Post hoc tests (Tukey’s HSD): Veh/Scr vs. Veh/Ant22: n.s, p = 0.922; ∗∗Veh/Scr vs. KA/Scr:
p = 0.001, ∗∗∗KA/Scr vs. KA/Ant22: p < 0.001. (E) Example of PSD95-GFP-positive, newly-formed neuron in ectopic location in dentate hilus in an epileptic
Ant22-treated mouse 6 weeks following transfection with PSD95-GFP virus and graph showing percentage of PSD95-GFP-positive, newly-formed neurons found
ectopically in dentate hilus (Student’s t-test: KA/Scr vs. KA/Ant22: ∗t8 = 2.02, p = 0.039. (F) Graph showing increased distance traveled across the granule cell layer
by IdU-positive neurons 6 weeks following SE (two-Way ANOVA: Scr vs. Ant22: ∗F(1,16) = 8.32, p = 0.011; Veh vs. KA: ∗∗∗F(1,16) = 92.83, p < 0.001; Interaction:
∗F(1,16) = 8.208, p = 0.011. Post hoc tests (Tukey’s HSD): Veh/Scr vs. Veh/Ant22: n.s, p = 1.000; ∗∗Veh/Scr vs. KA/Scr: p = 0.001; ∗∗KA/Scr vs. KA/Ant22:
p = 0.004. (G) IdU-positive cells found ectopically in the contralateral hilus of the DG of epileptic Scr-treated mice 6 weeks following SE. Ectopic contralateral hilar
cell count was exacerbated in epileptic Ant22-treated mice. Student’s t-test: KA/Scr vs. KA/Ant22: ∗t8 = 2.52, p = 0.018. (H) Representative image of
PSD95-GFP-positive neurons in the contralateral DG of epileptic Ant22 mice 6 weeks following virus infection. Note, newly-formed neurons are all DCX-negative.
DCX in red, DAPI in blue and PSD95-GFP transfected cells in green. Scale bar = 50 µm.
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FIGURE 4 | Ant22 reduces complexity of the dendritic tree, independently of SE. (A) Representative images of dendritic trees of PSD95-GFP-positive neurons of the
four treatment groups (Scr and Ant22 control and epileptic mice 6 weeks following virus injection). Scale bar = 50 µm. (B) Dendritic length (combined length of entire
dendritic tree) of all four treatment groups. Two-Way ANOVA: Scr vs. Ant22: F(1,204) = 12.19, p < 0.001; Veh vs. KA: n.s, F(1,204) = 0.97, p = 0.319; Interaction: n.s.
F(1,204) = 0.00, p = 986. Post hoc tests (Tukey’s HSD): Veh/Scr vs. Veh/Ant22: n.s. p = 0.066; Veh/Scr vs. KA/Scr: n.s. p = 0.867; KA/Scr vs. KA/Ant22: n.s.
(Continued)
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FIGURE 4 | Continued
p = 0.070. (C) Cartoon illustrating Sholl analysis. Concentric circles at 50 µm
intervals. Number of branches crossing at each interval are counted. (D) Sholl
analysis of dendritic trees from four treatment groups. Branching was analyzed
every 50 µm. (E) Schoenen Ramification Index (SRI) of dendritic trees from the
four treatment groups showing decreased branching in GFP-positive cells in
Ant22-treated mice. Two-way ANOVA: Scr. vs. Ant22: ∗F(1,197) = 5.100,
p = 0.025; Veh. vs. KA: F(1,197) = 2.767, p = 0.098, n.s; Interaction:
F(1,197) = 1.54, p = 0.216, n.s). Post hoc tests (Tukey’s HSD): Veh/Scr vs.
Veh/Ant22: n.s. p = 0.172; Veh/Scr vs. KA/Scr: n.s. p = 0.062; KA/Scr vs.
KA/Ant22: n.s. p = 0.99. (F) Effect of Ant22-treatment and SE on dendritic
diameter (two-Way ANOVA: Scr vs. Ant22: n.s. F(1,16) = 2.19, p = 0.157; Veh
vs. KA: n.s. F(1,16) = 4.20, p = 0.0527; Interaction: n.s. F(1,16) = 4.33,
p = 0.054; Post hoc tests (Tukey’s HSD): Veh/Scr vs. Veh/Ant22: n.s.
p = 0.977; Veh/Scr vs. KA/Scr: n.s. p = 1.000; KA/Scr vs. KA/Ant22: n.s.
p = 0.095; ∗Veh/Ant22 vs. KA/Ant22: p = 0.044. (G) Graph showing increase
in dendritic diameter in Ant22-treated mice following SE at higher dendritic
orders (Repeated Measures Two-way ANOVA: F3,85 = 14.45, p < 0.001; post
hoc test (Bonferroni): ##Scr/KA vs. Ant22/KA, t = 3.882, p < 0.001).
in reduced dendritic growth and altering branching of the
dendritic tree even in the absence of a pathological insult.
A further effect on diameter of dendrites can be observed
when miR-22 is inhibited in mice previously subjected
to SE.
MicroRNA-22 Inhibition Increases Spine
Density and Spine Volume in
Newly-Formed Neurons Following Status
Epilepticus
We next investigated dendritic spine density and volume in
GFP-labeled new-born neurons, which are important contact
points for excitatory synaptic input and associated with
excitability and may be altered in epileptogenesis (Wong and
Guo, 2013). Inhibition of miR-22 had no effects on the density
of dendritic spines in GFP-labeled cells in non-seizure mice
(Figures 5A,B). The combination of SE and Ant22 treatment,
however, led to an elevation in spine density (Figures 5A,B),
particularly at higher dendritic orders (Figure 5C). Not only
did miR-22 suppression in combination with SE increase the
number of dendritic spines, but the average volume of the
spines was also increased (Figure 5D). Unlike with spine density,
however, this change was consistent across dendritic orders
(Figure 5E).
Mushroom-shaped spines (Figure 5F) are indicative of a fully
mature spine and these spines tend to have an increased density
of neurotransmitter receptors and therefore more efficiently
translate inputs into an action potential (Sultan et al., 2015). The
ratio of mushroom/non-mushroom-like spines was unaffected
by Ant22 in control mice, but was increased following SE,
and this SE-induced effect was exacerbated in the presence of
Ant22 (Figure 5G). The increased percentage of mushroom
spines in SE Ant22-treated mice was most pronounced at
higher dendritic orders (Figure 5H). Inhibition of miR-22
after SE therefore leads to an increase in spine density,
spine volume and a mushroom-like morphology on newly-
formed neurons possibly contributing to an aggravated epileptic
phenotype.
DISCUSSION
The present study is the first reported involvement of miRNAs
in mediating SE-induced aberrant AHN. An increasing number
of studies have demonstrated that dysregulation of the miRNA
profile is both a consequence of, and functional contributor
to epileptogenesis (Gorter et al., 2014; Brennan and Henshall,
2018) and miRNAs have also been implicated in each step of
neurogenesis (Makeyev et al., 2007; Han et al., 2016; Santos et al.,
2016; Mahmoudi and Cairns, 2017). A contribution of miRNA to
mediating the aberrant AHN initiated by SE, however, has not,
until now, been established. We have previously demonstrated
that miR-22 functions as an endogenous antiepileptogenic agent,
supressing the establishment of a contralateral epileptic focus
(Jimenez-Mateos et al., 2015). Here, we demonstrate that miR-22
upregulation in the neurogenic subgranular zone of the DG
persists for weeks following SE, where it acts to put a brake on
aberrant AHN. Suppression of miR-22, prior to the induction of
SE, exacerbates aberrant AHN in the contralateral hippocampus
of mice. This effect is not limited to the number of new neurons
produced, but also to their migratory path, dendritic morphology
and the density, volume and morphological maturity of their
dendritic spines.
It is now well established that experimentally-induced SE
leads to a sustained period of elevated AHN in the DG of rodents
(Parent et al., 1997; Gray and Sundstrom, 1998; Jessberger
et al., 2007; Jessberger and Parent, 2015). To our knowledge,
however, this is the first demonstration of bilateral aberrant
AHN, following unilateral injection of a chemoconvulsant,
suggesting that SE with a focal onset may promote aberrant
AHN at distal locations. While this is an important finding
in itself, it has also allowed us to investigate neurogenesis
in the contralateral DG, in the absence of the potentially
confounding effects of wide-scale neuronal death (Mouri et al.,
2008).
The principal finding of this study is that a unilateral
injection of KA induces an increased rate of neurogenesis in
the contralateral hippocampus and that this aberrant AHN is
exacerbated by miR-22 inhibition. Previous reports of miR-22
involvement in neurogenesis are scarce, however Berenguer
et al. (2013) report that this miRNA lengthens the cell cycle
and suppresses cerebellar granule neuron precursor proliferation
during development. We also demonstrate that miR-22 plays
a role in maintaining the integrity of migratory pathways
and reducing the number of newly-formed neurons located
ectopically in the hilus and reducing the average distance
traveled by these cells across the granule cell layer. Aberrant
migration of new neurons following SE in rodent models is
well-documented (Jessberger et al., 2005, 2007; Walter et al.,
2007), however, this is the first report in the contralateral
DG following unilateral chemoconvulsant injection. We did
not establish the mechanism through which miR-22 controls
migration, however, DCX, a microtubule-interacting protein
associated with the migration of immature neurons (Tang et al.,
2014), is a target of miR-22 (von Bohlen und Halbach, 2007)
via components of the CoREST/REST transcriptional repressor
complex (Volvert et al., 2014).
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FIGURE 5 | MiR-22 inhibition increases spine density and volume on dendrites of newly-formed neurons following SE. (A) Representative images showing increased
spine density in Ant22-treated epileptic mice when compared to Scr-treated epileptic mice. Dendrites are shown in red and spines in green (arrows). Scale
bar = 20 µm. (B) Graph showing that SE increases spine density and that this is exacerbated by Ant22 treatment (two-way ANOVA: Scr vs. Ant22: n.s.
F(1,36) = 2.34, p = 0.135; Veh vs. KA: F(1,36) = 11.26, p = 0.002; Interaction: n.s. F(1,36) = 2.47, p = 0.125). Post hoc tests (Tukey’s HSD): Veh/Scr vs. Veh/Ant22: n.s.
p = 1.000; Veh/Scr vs. KA/Scr: n.s. p = 0.593; KA/Scr vs. KA/Ant22: n.s. p = 0.144; ∗∗Veh/Ant22 vs. KA/Ant22: p = 0.007. (C) Elevated spine density in
Ant22-treatd mice following SE most pronounced at higher dendritic orders: Repeated-measures ANOVA: F(3,198) = 92.16, p < 0.0001, post hoc test (Bonferroni;
scramble KA vs. antagomir KA): #t = 2.840, p < 0.05 (order ii); #t = 3.112 (order iii), p < 0.05; ###t = 4.384, p < 0.001 (order iv); ##t = 3.069, p < 0.01 (order v);
###t = 4.421, p < 0.001 (order vi). (D) Graph showing average spine volume increased following KA-induced SE in Ant22-treated mice, compared with Scr-treated
controls (two-Way ANOVA: Scr vs. Ant22: F(1,26) = 5.87 p = 0.023; Veh vs. KA: n.s. F(1,26) = 2.933, p = 0.099; Interaction: F(1,26) = 5.66, p = 0.025. Post hoc tests
(Tukey’s HSD): Veh/Scr vs. Veh/Ant22: n.s. p = 1.000; Veh/Scr vs. KA/Scr: n.s. p = 0.910; ∗KA/Scr vs. KA/Ant22: p = 0.011; ∗Veh/Ant22 vs. KA/Ant22: p = 0.048.
(E) Increased spine volume in KA and Ant22-treated mice consistent across all dendritic orders (Repeated Measures ANOVA: F(3,80) = 32.26, p < 0.0001; post hoc
test (Bonferroni; scramble KA vs. antagomir/KA): #t = 2.840, p < 0.05 (order ii); #t = 3.112, p < 0.05 (order iii); ###t = 4.384, p < 0.001 (order iv); ##t = 3.609,
p < 0.01 (order v); ###t = 4.421, p < 0.001 (order vi)). (F) Examples of mushroom-shaped and non-mushroom shaped spines. Spines with a head diameter greater
than 0.4 µm and a head/neck ratio greater than 1.2 (Bourne and Harris, 2011) were considered “mushroom-shaped.” Scale bar = 0.5 µm. (G) Ratio of
mushroom/non-mushroom shaped spines increased following KA-induced SE in Ant22-treated mice, compared with Scr-treated controls (two-way ANOVA: Scr vs.
Ant22: F(1,36) = 4.95, p = 0.032; Veh vs. KA: F(1,36) = 10.22, p = 0.003; Interaction: F(1,36) = 4.35, p = 0.044. Post hoc tests (Tukey’s HSD): Veh/Scr vs. Veh/Ant22:
n.s. p = 1.000; Veh/Scr vs. KA/Scr: n.s. p = 0.861; ∗KA/Scr vs. KA/Ant22: p = 0.021; ∗∗Veh/Ant22 vs. KA/Ant22: p = 0.003. (H) Increased density of
mushroom-shaped spines in mice following treatment with Ant22 and 6 weeks following KA-induced SE most marked at higher dendritic orders (Repeated
Measures ANOVA: F(3,198) = 59.24, p < 0.0001; post hoc test (Bonferroni; scramble/KA vs. antagomir/KA): #t = 2.827, p < 0.05 (order iii); ###t = 4.351, p < 0.001
(order iv); ###t = 6.069, p < 0.001 (order v); ###t = 7.737, p < 0.001 (order vi)).
Furthermore, we report that while SE had no impact on the
length of branching of the dendritic tree, miR-22 inhibition
reduced dendritic length, independently of KA treatment.
This suggests that miR-22, besides its role in suppressing
aberrant AHN, also plays a role in dendritic arborization
under normal conditions. A major finding in the present
study was that miR-22 inhibition combined with SE led to a
marked increase in dendritic diameter. No change in dendritic
diameter of newly-formed neurons was found to result from
SE in Scr-treated mice, in contrast to the findings of Arisi
and Garcia-Cairasco (Arisi and Garcia-Cairasco, 2007), who
reported a decrease in dendritic diameter in a pilocarpine rat
model.
Neither SE nor miR-22 inhibition in isolation had any
effect on spine density, volume or morphological maturity.
MiR-22 inhibition and SE together, however, increased the
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density of spines, spine volume and an increased percentage of
spines adopting a mature ‘‘mushroom-like’’ morphology. This
suggests that miR-22 is responsible for suppressing SE-driven
alterations in growth and shape of dendritic spines. Whether
this effect is restricted to newly-formed neurons or reflects
plastic changes in the granule cell population at large, is unclear.
In contrast to our findings, most authors have reported a
reduction in spine density following SE (Murphy and Danzer,
2011). Isokawa (Isokawa, 2000), however, demonstrated that
this reduction is short-lived in the pilocarpine rat model
and within 35 days, spine density was significantly higher
than normal levels. Our finding that SE alone had no effect
on spine density may therefore be a specific effect of the
time-point analyzed. Murphy et al. (2011) suggest that neurons
born shortly after SE include two subpopulations; one with a
decreased number of spines and one with an increased number
of spines. An alternative explanation for the pro-spinogenic
effect of miR-22 is that it is involved in selective targeting
of one subpopulation for phagocytosis and that the apparent
increase in average spine density, in fact represents the
selective sparing of the second subpopulation. This may also
offer an alternative explanation for changes seen in dendritic
diameter.
While our results demonstrate that inhibition of miR-22
exacerbates aberrant AHN, we have not established the
mechanism through which this occurs. Neuroinflammation
supresses neurogenesis in most cases, but it has become clear that
this relationship is more complicated than previously thought
(Ekdahl et al., 2009) and in the post-SE DG, inflammation may
be pro-neurogenic (Mishra et al., 2015). We have previously
demonstrated that P2X7, a key regulator of neuroinflammation,
is a target of miR-22 (Jimenez-Mateos et al., 2015). It is possible
that miR-22 control of AHN may be secondary to control of
inflammatory pathways via P2X7. Further, while the severity
of SE is unchanged following Ant22 injection, the frequency
and severity of spontaneous epileptic seizures is increased
(Jimenez-Mateos et al., 2015). This may be related to network
level changes associated with aberrant AHN. This increase
in seizure severity, however, may also contribute to changes
in AHN.
The majority position is that an expansion in neurogenic
activity and dysregulation of migration of newly-formed neurons
contributes to network hyperexcitability and epileptogenesis
(Jung et al., 2004; Scharfman and Pierce, 2012; Cho et al.,
2015) and underlies comorbidities, by disrupting the normal
functioning of hippocampal networks (Myers et al., 2013).
Causality, however, is difficult to establish and some authors
have proposed that these processes, in fact, serve to repair
the injured brain (Sun et al., 2007), with hilar ectopic granule
cells contributing to inhibitory drive (Lacefield et al., 2012).
Others consider aberrant AHN an epiphenomena, offering
no contribution to epileptogenesis (Kondratiuk et al., 2015;
Neuberger et al., 2017; Zhu et al., 2018), while the long-term
costs incurred by the depletion of the neurogenic pool,
including an increased susceptibility to seizures, may be
of greater consequence (Sierra et al., 2015). While most of
the evidence from rodent models suggests an instrumental
role for aberrant AHN in epileptogenesis (Cho et al., 2015),
some doubts have been raised regarding the relevance of
AHN to humans, with Sorrells et al. (2018) reporting no
AHN detectable above age 13 (Sorrells et al., 2018). This
potentially calls into question the relevance of findings from
rodent models of disease. The matter remains, however,
highly contentious, with subsequent reports of persistent
human AHN (Boldrini et al., 2018) and disagreements over
the interpretation of cellular markers. Further, evidence
suggests a dissociation between age-related decline in basal
rates of AHN and status-epilepticus induced elevations, at
least in rodents (Gray and Sundstrom, 1998). This suggests
that, even in the case that AHN does not occur in humans
under normal conditions, insult-induced aberrant AHN is
likely still of clinical relevance. This is supported by consistent
clinical findings of hilar ectopic granule cells in tissue resected
from TLE patients, suggestive of a period of aberrant AHN
(Althaus et al., 2015). MiR-22 may be involved in modulating
SE-driven dendritic morphogenesis and spinogenesis on
newly-formed neurons, or, alternatively, the observed effects
may be the consequence of miR-22 control over differential
survival. Either way, the consequences of increased dendritic
diameter are likely to include increased efficiency in synaptic
integration, larger post-synaptic currents and ultimately,
an increase in neuronal excitability (Magee, 2000). While
dendritic spines are associated with excitatory synapses and
the increased density, volume and morphological maturity
may all contribute towards an increase in excitatory drive,
transmission and fidelity (Araya et al., 2006). The increased
excitability of individual neurons is likely to translate into
network-wide hyperexcitability and a reduced threshold for
ictogenesis.
CONCLUSION
The present study is the first to demonstrate a role for miRNAs
in mediating SE-driven expansion in neurogenic activity.
We have previously demonstrated that miR-22 supresses the
emergence of a secondary, contralateral epileptic focus, through
modulation of neuroinflammatory pathways via suppression
of P2X7, thereby acting as an endogenous antiepileptogenic
agent (Jimenez-Mateos et al., 2015). Here, we report that
miR-22 acts as a brake on aberrant AHN, adding to the
evidence that miR-22 plays a multi-faceted role in supressing
the development of TLE and suggesting that it may represent
an attractive candidate for designing a disease-modifying
intervention.
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